Histamine induces interleukin-6 expression in the human synovial sarcoma cell line (SW982) through the H1 receptor

Inflammation Research

Volumn 55, Issue 9, 2006, Pages 393-398

  Wang, S L ^a   Malany, S ^a   Wang, Q ^a   Santos, M A ^a   Crowe, P D ^a   Maki, R A ^a  

^a NEUROCRINE BIOSCIENCES INC   (United States)

Author keywords

Arthritis; Cytokine; Histamine; Inflammation; Signal transduction

Indexed keywords

2 [1 (3 DIMETHYLAMINOPROPYL) 3 INDOLYL] 3 (3 INDOLYL)MALEIMIDE; CALCIUM; CIMETIDINE; HISTAMINE; HISTAMINE H1 RECEPTOR; HISTAMINE H1 RECEPTOR ANTAGONIST; HISTAMINE H2 RECEPTOR; HISTAMINE H2 RECEPTOR ANTAGONIST; INOSITOL PHOSPHATE; INTERLEUKIN 6; MEPYRAMINE; PHOSPHATIDYLINOSITIDE; PROTEIN KINASE C; PROTEIN KINASE C INHIBITOR; TRITIUM;

ARTICLE; BINDING AFFINITY; CALCIUM MOBILIZATION; CELL MEMBRANE; CONTROLLED STUDY; CYTOKINE RELEASE; DRUG POTENCY; DRUG RECEPTOR BINDING; HUMAN; HUMAN CELL; INFLAMMATION; RHEUMATOID ARTHRITIS; SIGNAL TRANSDUCTION; STATISTICAL SIGNIFICANCE; SYNOVIAL SARCOMA;

CELL LINE, TUMOR; CIMETIDINE; HISTAMINE; HISTAMINE H1 ANTAGONISTS; HISTAMINE H2 ANTAGONISTS; HUMANS; INDOLES; INTERLEUKIN-6; MALEIMIDES; PROTEIN KINASE C; PROTEIN KINASE INHIBITORS; RECEPTORS, HISTAMINE H1; SARCOMA, SYNOVIAL;

EID: 37849186095     PISSN: 10233830     EISSN: 1420908X     Source Type: Journal    
DOI: 10.1007/s00011-006-6020-3     Document Type: Article

References (35)

1. Brown RE, Stevens DR, Haas HL. The physiology of brain histamine. Prog Neurobiol 2001; 63(6): 637-72.
2. Repka-Ramirez MS, Baraniuk JN. Histamine in health and disease. Clin Allergy Immunol 2002; 17: 1-25.
3. Ring J, Histamine and allergic disease. In new trends in allergy 1985; 44-77.
4. Leurs R, Smit MJ, Timmerman H. Molecular pharmacological aspects of histamine receptors. Pharmacol Ther 1995; 66(3): 413-63.
5. Schneider E, Rolli-Derkinderen M, Arock M, Dy M. Trends in histamine research: new functions during immune responses and hematopoiesis. Trends Immunol 2002; 23(5): 255-63.
6. Lovenberg TW, Roland BL, Wilson SJ, Jiang X, Pyati J, Huvar A et al. Cloning and functional expression of the human histamine H3 receptor. Mol Pharmacol 1999; 55(6): 1101-7.
7. Oda T, Morikawa N, Saito Y, Masuho Y, Matsumoto S. Molecular cloning and characterization of a novel type of histamine receptor preferentially expressed in leukocytes. J Biol Chem 2000; 275(47): 36781-6.
8. Allansmith MR, Ross RN. Ocular allergy. Clin Allergy 1988; 18(1): 1-13.
9. Abelson MB, Schaefer K. Conjunctivitis of allergic origin: immunologic mechanisms and current approaches to therapy. Surv Ophthalmol 1993; 38 Suppl: 115-32.
10. Sharif NA, Crider JY, Griffin BW, Davis TL, Howe WE. Pharmacological analysis of mast cell mediator and neurotransmitter receptors coupled to adenylate cyclase and phospholipase C on immunocytochemically-defined human conjunctival epithelial cells. J Ocul Pharmacol Ther 1997; 13(4): 321-36.
11. Gamache DA, Dimitrijevich SD, Weimer LK, Lang LS, Spellman JM, Graff G et al. Secretion of proinflammatory cytokines by human conjunctival epithelial cells. Ocul Immunol Inflamm 1997; 5(2): 117-28.
12. 2+-mobilization and cytokine release from human corneal epithelial cells. Br J Pharmacol 1998; 125(6): 1336-44.
13. 2+-dependent protein kinase C, Raf/MEK/ERK and IKK/I kappa B/NF-kappa B signal cascades. Biochem Pharmacol 2005; 69(3): 433-49.
14. Cadman ED, Witte DG, Lee CM. Regulation of the release of interleukin-6 from human astrocytoma cells. J Neurochem 1004; 63(3): 980-7.
15. Hill SJ, Ganellin CR, Timmerman H, Schwartz JC, Shankley NP, Young JM et al. International Union of Pharmacology. XIII. Classification of histamine receptors. Pharmacol Rev 1997; 49(3): 253-78.
16. Curran MP, Scott LJ, Perry CM. Cetirizine: a review of its use in allergic disorders. Drugs 2004; 64(5): 523-61.
17. Arend WP, Dayer JM. Inhibition of the production and effects of interleukin-1 and tumor necrosis factor alpha in rheumatoid arthritis. Arthritis Rheum 1995; 38(2): 151-60.
18. Firestein GS, Alvaro-Gracia JM, Maki R. Quantitative analysis of cytokine gene expression in rheumatoid arthritis. J Immunol 1990; 144(9): 3347-53.
19. Miyazawa K, Mori A, Yamamoto K, Okudaira H. Constitutive transcription of the human interleukin-6 gene by rheumatoid synoviocytes: spontaneous activation of NF-kappaB and CBF1. Am J Pathol 1998; 152(3): 793-803.
20. Tsuji F, Oki K, Senda T, Horiuchi M, Mita S. Effects of mitogen-activated protein kinase inhibitors or phosphodiesterase inhibitors on interleukin-1-induced cytokines production in synovium-derived cells. Immunol Lett 1999; 68(2-3): 275-9.
21. Yamazaki T, Yokoyama T, Akatsu H, Tukiyama T, Tokiwa T. Phenotypic characterization of a human synovial sarcoma cell line, SW982, and its response to dexamethasone. In Vitro Cell Dev Biol Anim 2003; 39(8-9): 337-9.
22. Hill SJ. Distribution, properties, and functional characteristics of three classes of histamine receptor. Pharmacol Rev 1990; 42(1): 45-83.
23. Bakker RA, Wieland K, Timmerman H, Leurs R. Constitutive activity of the histamine H(1) receptor reveals inverse agonism of histamine H(1) receptor antagonists. Eur J Pharmacol 2000; 387(1): R5-7.
24. Fitzsimons CP, Monczor F, Fernandez N, Shayo C, Davio C. Mepyramine, a histamine H1 receptor inverse agonist, binds preferentially to a G protein-coupled form of the receptor and sequesters G protein. J Biol Chem 2004; 279(33): 34431-9.
25. Delneste Y, Lassalle P, Jeannin P, Joseph M, Tonnel AB, Gosset P. Histamine induces IL-6 production by human endothelial cells. Clin Exp Immunol 1994; 98(2): 344-9.
26. Triggiani M, Gentile M, Secondo A, Granata F, Oriente A, Taglialatela M. et al. Histamine induces exocytosis and IL-6 production from human lung macrophages through interaction with H1 receptors. J Immunol 2001; 166(6): 4083-91.
27. Noah TL, Paradiso AM, Madden MC, McKinnon KP, Devlin RB. The response of a human bronchial epithelial cell line to histamine: intracellular calcium changes and extracellular release of inflammatory mediators. Am J Respir Cell Mol Biol 1991; 5(5): 484-92.
28. Del Valle J, Gantz I. Novel insights into histamine H2 receptor biology. Am J Physiol 1997; 273(5 Pt 1): G987-96.
29. Woolley DE, Tetlow LC. Mast cell activation and its relation to proinflammatory cytokine production in the rheumatoid lesion. Arthritis Res 2000; 2(1): 65-74.
30. He S, Gaca MD, Walls AF. The activation of synovial mast cells: modulation of histamine release by tryptase and chymase and their inhibitors. Eur J Phamiacol 2001; 412(3): 223-9.
31. Crisp AJ, Chapman CM, Kirkham SE, Schiller AL, Krane SM. Articular mastocytosis in rheumatoid arthritis. Arthritis Rheum 1984; 27(8): 845-51.
32. Buckley MG, Gallagher PJ, Walls AF. Mast cell subpopulations in the synovial tissue of patients with osteoarthritis: selective increase in numbers of tiyptase-positive, chymase-negative mast cells. J Pathol 1998; 186(1): 67-74.
33. Punzi L, Calo L, Plebani M. Clinical significance of cytokine determination in synovial fluid. Crit Rev Clin Lab Sci 2002; 39(1): 63-88.
34. van Leeuwen MA, Westra J, Limburg PC, van Riel PL, van Rijswijk MH. Clinical significance of interleukin-6 measurement in early rheumatoid arthritis: relation with laboratory and clinical variables and radiological progression in a three year prospective study. Ann Rheum Dis 1995; 54(8): 674-7.
35. van Leeuwen MA, Westra J, Limburg PC, van Riel PL, van Rijswijk MH. Interleukin-6 in relation to other proinflammatory cytokines, chemotactic activity and neutrophil activation in rheumatoid synovial fluid. Ann Rheum Dis 1995; 54(1): 33-8.